It is now widely accepted that the TGF-beta signaling pathways can both suppress tumor formation and promote tumor progression and that both effects are mediated largely through tumor cell autonomous TGF-beta signaling. Data generated during this grant period with conditional knockout of TGF-beta signaling in epithelia support the hypothesis that epithelial cell autonomous TGF-beta signaling is tumor suppressive and demonstrate that metastases can not only occur but are enhanced with knockout of the type II TGF-beta receptor (Tgfbr2) in mammary carcinoma cells. However, systemic inhibition of TGF-beta signaling markedly suppressed pulmonary metastases in the MMTV-c-neu/DNIIR mice. This indicates that the effect of systemic inhibitors of TGF-beta in suppressing metastasis is largely on host cells. These results have modified our hypotheses concerning the mechanism of TGF-beta promotion of tumor progression. We now propose that tumor cell autonomous signaling by TGF-beta can suppress rather than enhancing metastases, and that TGF-beta signaling in host cells is a significant component of both the tumor suppressive and the tumor promotion effects of TGF-beta in vivo. We will test these hypotheses through the following specific aims by determining the changes in the carcinoma cells and their microenvironment associated with knockout of the type II TGF-beta receptor gene, Tgfbr2, in tumor cells that lead to increased metastases.
Specific Aim 1. Determine the effects of systemic inhibition of TGF-beta signaling on mammary tumor formation and metastases from MMTV-c-neu and MMTV-PyVmT-induced mammary tumors in the context Tgfbr2 knockout in mammary epithelial cells effected by both MMTV-Cre and WAP-Cre.
Specific Aim 2. Determine the influence of timing of loss of TGF-beta signaling during mammary tumor formation and progression on metastatic spread using inducible MMTV-Cre.
Specific Aim 3. Determine mechanisms for enhanced metastatic capability with loss of tumor cell TGF-beta signaling by examining both tumor cells and their microenvironment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA085492-06A1
Application #
7038424
Study Section
Tumor Cell Biology Study Section (TCB)
Program Officer
Mohla, Suresh
Project Start
2000-05-20
Project End
2010-11-30
Budget Start
2005-12-15
Budget End
2006-11-30
Support Year
6
Fiscal Year
2006
Total Cost
$401,834
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Tharp, Kevin M; Weaver, Valerie M (2018) Modeling Tissue Polarity in Context. J Mol Biol 430:3613-3628
Gilbert, Penney M; Weaver, Valerie M (2017) Cellular adaptation to biomechanical stress across length scales in tissue homeostasis and disease. Semin Cell Dev Biol 67:141-152
Lehmann, Brian D; Jovanovi?, Bojana; Chen, Xi et al. (2016) Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection. PLoS One 11:e0157368
Ou, Guanqing; Thakar, Dhruv; Tung, Jason C et al. (2016) Visualizing mechanical modulation of nanoscale organization of cell-matrix adhesions. Integr Biol (Camb) 8:795-804
Kai, FuiBoon; Laklai, Hanane; Weaver, Valerie M (2016) Force Matters: Biomechanical Regulation of Cell Invasion and Migration in Disease. Trends Cell Biol 26:486-497
Kaushik, Shelly; Pickup, Michael W; Weaver, Valerie M (2016) From transformation to metastasis: deconstructing the extracellular matrix in breast cancer. Cancer Metastasis Rev 35:655-667
Oudin, Madeleine J; Weaver, Valerie M (2016) Physical and Chemical Gradients in the Tumor Microenvironment Regulate Tumor Cell Invasion, Migration, and Metastasis. Cold Spring Harb Symp Quant Biol 81:189-205
Hover, Laura D; Abel, Ty W; Owens, Philip (2015) Genomic Analysis of the BMP Family in Glioblastomas. Transl Oncogenomics 7:1-9
Shaw, Aubie K; Pickup, Michael W; Chytil, Anna et al. (2015) TGF? signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions. PLoS One 10:e0117908
Hover, Laura D; Young, Christian D; Bhola, Neil E et al. (2015) Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth. Cancer Lett 368:79-87

Showing the most recent 10 out of 70 publications